Atlas Trials

Efficacy and Safety of Nitazoxanide 600 mg to Treat Mild Ambulatory COVID-19 Patients

Clinical trial NCT04441398 · WITHDRAWN

Trial details

NCT number
NCT04441398
Sponsor
Azidus Brasil
Status
WITHDRAWN
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
covid19
Start date
2020-07-01
Primary completion
2020-09-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.